RU2219926C2 - Чрескожная терапевтическая система (чтс), содержащая антиоксидант - Google Patents
Чрескожная терапевтическая система (чтс), содержащая антиоксидант Download PDFInfo
- Publication number
- RU2219926C2 RU2219926C2 RU2000120951/15A RU2000120951A RU2219926C2 RU 2219926 C2 RU2219926 C2 RU 2219926C2 RU 2000120951/15 A RU2000120951/15 A RU 2000120951/15A RU 2000120951 A RU2000120951 A RU 2000120951A RU 2219926 C2 RU2219926 C2 RU 2219926C2
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- antioxidant
- amount
- composition according
- tocopherol
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Fats And Perfumes (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Dental Preparations (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Изобретение относится к фармацевтике и касается фармацевтической композиции, включающей (S)-N-этил-3-[1-диметиламино)этил]-N-метилфенилкарбамат и антиоксидант, обладающей повышенной стабильностью, а также устройства для ее трансдермального введения. 2 с. и 5 з. п.ф-лы.
Description
Текст описания в факсимильном виде (см. графическую часть).
Claims (7)
1. Фармацевтическая композиция, включающая (S)-N-этил-3-[1-диметиламино)этил] -N-метилфенилкарбамат (соединение А) в форме свободного основания или в форме кислотно-аддитивной соли и антиоксидант.
2. Фармацевтическая композиция по п.1, включающая 1-40 мас.% соединения А в форме свободного основания или в форме кислотно-аддитивной соли.
3. Фармацевтическая композиция по п.1 или 2, в которой антиоксидант представляет собой токоферол, его сложные эфиры, аскорбиновую кислоту, бутилгидрокситолуол, бутилгидроксианизол или пропилгаллат, аскорбилпальмитат, предпочтительно α-токоферол или аскорбилпальмитат.
4. Фармацевтическая композиция по любому из предыдущих пунктов, в которой антиоксидант присутствует в количестве от примерно 0,01 до примерно 0,5% в пересчете на массу фармацевтической композиции.
5. Фармацевтическая композиция по любому из предыдущих пунктов, в которой антиоксидант токоферол присутствует в количестве 0,1% в пересчете на массу фармацевтической композиции.
6. Фармацевтическая композиция по п.1, включающая а) соединение А в форме свободного основания в количестве 20-40 мас.%, б) полиметакрилат в количестве 10-30 мас.%, в) сополимер акрилата в количестве 40-60 мас.% и г) α-токоферол в количестве 0,05-0,3 мас.%, где общая масса фармацевтической композиции принята за 100%.
7. Трансдермальное устройство, включающее фармацевтическую композицию по п.1, защитный слой, являющийся подложкой для фармацевтической композиции, адгезив для контакта и фиксации фармацевческой композиции к защитному слою и разъединяющую прокладку, при отсутствии контакта которой с этим адгезивом она может быть отделена.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9800526.7 | 1998-01-12 | ||
GBGB9800526.7A GB9800526D0 (en) | 1998-01-12 | 1998-01-12 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000120951A RU2000120951A (ru) | 2002-08-10 |
RU2219926C2 true RU2219926C2 (ru) | 2003-12-27 |
Family
ID=10825116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000120951/15A RU2219926C2 (ru) | 1998-01-12 | 1999-01-08 | Чрескожная терапевтическая система (чтс), содержащая антиоксидант |
Country Status (26)
Country | Link |
---|---|
US (1) | US6335031B1 (ru) |
EP (1) | EP1047409B1 (ru) |
KR (1) | KR100569051B1 (ru) |
CN (1) | CN1129427C (ru) |
AT (1) | ATE223711T1 (ru) |
AU (1) | AU745661B2 (ru) |
BR (1) | BR9906920A (ru) |
CA (1) | CA2315784C (ru) |
CZ (1) | CZ300598B6 (ru) |
DE (1) | DE69902875T2 (ru) |
DK (1) | DK1047409T3 (ru) |
ES (1) | ES2184408T3 (ru) |
GB (1) | GB9800526D0 (ru) |
HK (1) | HK1034036A1 (ru) |
HU (1) | HU227159B1 (ru) |
ID (1) | ID27503A (ru) |
IL (1) | IL137100A (ru) |
MX (1) | MXPA00006438A (ru) |
NO (1) | NO328390B1 (ru) |
NZ (1) | NZ505650A (ru) |
PL (1) | PL201328B1 (ru) |
PT (1) | PT1047409E (ru) |
RU (1) | RU2219926C2 (ru) |
SK (1) | SK284622B6 (ru) |
TR (2) | TR200001688T2 (ru) |
WO (1) | WO1999034782A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2450805C2 (ru) * | 2005-12-01 | 2012-05-20 | Новартис Аг | Трансдермальная терапевтическая система |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID27504A (id) * | 1998-10-01 | 2001-04-12 | Novartis Ag | Formulasi oral baru |
FR2793689B1 (fr) * | 1999-05-19 | 2001-08-24 | Pf Medicament | Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives |
PL198323B1 (pl) * | 1999-11-29 | 2008-06-30 | Lohmann Therapie Syst Lts | Transdermalny system terapeutyczny zawierający wrażliwe na utlenianie substancje czynne i sposób jego wytwarzania |
DE10107663B4 (de) * | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
ITMI20020798A1 (it) * | 2002-04-15 | 2003-10-15 | F T Holding S A | Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici |
FR2881653A1 (fr) * | 2005-02-04 | 2006-08-11 | Frederic Khodja | Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine |
WO2009022345A1 (en) * | 2007-08-14 | 2009-02-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Phenyl carbamates for the treatment of multiple sclerosis |
EP2309985B1 (en) | 2008-07-28 | 2018-03-14 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
BR112012017168B1 (pt) | 2009-12-22 | 2022-03-15 | Luye Pharma Ag | Sistemas terapêuticos transdérmicos, seu processo de preparação, e usos de um polímero ou copolímero |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
ES2363395B1 (es) * | 2010-01-20 | 2012-02-23 | Farmalider, S.A. | Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral. |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
CN103068944B (zh) | 2010-07-21 | 2016-03-09 | 3M创新有限公司 | 透皮粘合剂组合物、装置及方法 |
PL2468274T3 (pl) | 2010-12-14 | 2015-11-30 | Luye Pharma Ag | Przezskórny układ terapeutyczny do podawania substancji czynnej |
KR101788802B1 (ko) * | 2010-12-24 | 2017-10-20 | 주식회사 삼양바이오팜 | 리바스티그민을 함유하는 경피흡수제제 |
KR20120126898A (ko) * | 2011-05-13 | 2012-11-21 | 에스케이케미칼주식회사 | 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물 |
KR20120130073A (ko) * | 2011-05-20 | 2012-11-28 | 에스케이케미칼주식회사 | 리바스티그민 함유 패취 |
BR112013029945A2 (pt) | 2011-05-20 | 2017-01-31 | Sk Chemicals Co Ltd | emplastro contendo rivastigmina |
EP2594261A1 (en) | 2011-11-18 | 2013-05-22 | Labtec GmbH | Composition for transdermal administration of rivastigmine |
DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
WO2013142339A1 (en) | 2012-03-23 | 2013-09-26 | Novartis Ag | Transdermal therapeutic system and method |
WO2013187451A1 (ja) | 2012-06-12 | 2013-12-19 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
US20150209302A1 (en) * | 2012-09-03 | 2015-07-30 | Nipro Patch Co., Ltd. | Adhesive skin patch |
KR20140038237A (ko) * | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
US9895320B2 (en) | 2012-09-28 | 2018-02-20 | KM Transderm Ltd. | Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer |
WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
US9949935B2 (en) * | 2014-04-08 | 2018-04-24 | Teikoku Pharma Usa, Inc. | Rivastigmine transdermal compositions and methods of using the same |
WO2015174502A1 (ja) | 2014-05-15 | 2015-11-19 | ニチバン株式会社 | リバスチグミンを含有する貼付剤のための包装体 |
KR20200025888A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
KR20200025883A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201906B (en) * | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
WO1998030243A1 (en) * | 1997-01-08 | 1998-07-16 | Warner-Lambert Company | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease |
EP0952826B1 (en) * | 1997-01-17 | 2001-11-14 | Takeda Chemical Industries, Ltd. | Idebenone containing combination agent for treating alzheimer's disease |
-
1998
- 1998-01-12 GB GBGB9800526.7A patent/GB9800526D0/en not_active Ceased
-
1999
- 1999-01-08 ES ES99902525T patent/ES2184408T3/es not_active Expired - Lifetime
- 1999-01-08 BR BR9906920-2A patent/BR9906920A/pt not_active Application Discontinuation
- 1999-01-08 PT PT99902525T patent/PT1047409E/pt unknown
- 1999-01-08 CA CA002315784A patent/CA2315784C/en not_active Expired - Lifetime
- 1999-01-08 TR TR2000/01688T patent/TR200001688T2/xx unknown
- 1999-01-08 IL IL13710099A patent/IL137100A/en not_active IP Right Cessation
- 1999-01-08 DK DK99902525T patent/DK1047409T3/da active
- 1999-01-08 RU RU2000120951/15A patent/RU2219926C2/ru active
- 1999-01-08 CN CN99802092A patent/CN1129427C/zh not_active Expired - Lifetime
- 1999-01-08 ID IDW20001301A patent/ID27503A/id unknown
- 1999-01-08 AU AU22785/99A patent/AU745661B2/en not_active Expired
- 1999-01-08 DE DE69902875T patent/DE69902875T2/de not_active Expired - Lifetime
- 1999-01-08 WO PCT/EP1999/000078 patent/WO1999034782A1/en active IP Right Grant
- 1999-01-08 TR TR2001/01021T patent/TR200101021T2/xx unknown
- 1999-01-08 HU HU0004300A patent/HU227159B1/hu unknown
- 1999-01-08 CZ CZ20002557A patent/CZ300598B6/cs not_active IP Right Cessation
- 1999-01-08 SK SK1053-2000A patent/SK284622B6/sk not_active IP Right Cessation
- 1999-01-08 MX MXPA00006438A patent/MXPA00006438A/es active IP Right Grant
- 1999-01-08 KR KR1020007006433A patent/KR100569051B1/ko active IP Right Review Request
- 1999-01-08 PL PL341347A patent/PL201328B1/pl unknown
- 1999-01-08 EP EP99902525A patent/EP1047409B1/en not_active Expired - Lifetime
- 1999-01-08 NZ NZ505650A patent/NZ505650A/xx not_active IP Right Cessation
- 1999-01-08 AT AT99902525T patent/ATE223711T1/de active
- 1999-04-14 US US09/291,498 patent/US6335031B1/en not_active Expired - Lifetime
-
2000
- 2000-07-05 NO NO20003472A patent/NO328390B1/no not_active IP Right Cessation
-
2001
- 2001-04-20 HK HK01102834A patent/HK1034036A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2450805C2 (ru) * | 2005-12-01 | 2012-05-20 | Новартис Аг | Трансдермальная терапевтическая система |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2219926C2 (ru) | Чрескожная терапевтическая система (чтс), содержащая антиоксидант | |
RU2000120951A (ru) | Чрескожная терапевтическая система (чтс), содержащая антиоксидант | |
US20200289426A1 (en) | Transdermal Therapeutic System for Administering an Active Substance | |
RU2553350C2 (ru) | Трансдермальные пластыри | |
US8962014B2 (en) | Transdermal therapeutic system for administering rivastigmine or derivatives thereof | |
CA2499093A1 (en) | Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. | |
US20130101660A1 (en) | Transdermal delivery patch | |
ES2897449T3 (es) | Sistema terapéutico transdérmico transparente que contiene nicotina | |
US6316023B1 (en) | TTS containing an antioxidant | |
US10076502B2 (en) | Transdermal therapeutic system for administering rivastigmine or derivatives thereof | |
AU2004271679B2 (en) | Agent containing ergolin for transdermal application | |
JP3820103B6 (ja) | 抗酸化剤含有tts |